New therapeutic target identified in spondyloarthritis
A new study published in Nature Communications identifies a key driver of joint and intestinal inflammation that could lead to future treatment of the chronic inflammatory disease.
Read moreCancer progression may be controlled by targeting tumor-specific extracellular matrix
Researchers have uncovered how tumors exploit tenascin-C to deflect the body’s natural defence against them.
Read moreA warm welcome to the Kennedy 2019 DPhil student intake
The Kennedy Institute welcomes a new intake of DPhil students supported by funders including the Kennedy Trust for Rheumatology Research, Wellcome Trust, BBSRC, British Heart Foundation and the National Institutes of Health Oxford-Cambridge.
Read moreKennedy Trust renews commitment to rheumatology research with £20M
The Kennedy Trust for Rheumatology Research (KTRR) has pledged a minimum of £20M over five years to the Kennedy Institute of Rheumatology at the University of Oxford to support pioneering research into chronic inflammatory disease.
Read moreKennedy Institute of Rheumatology
A world-leading medical research centre where discovery research drives the development of transformative therapies for chronic inflammatory and degenerative disease.
240 Staff, students and academic visitors
30 Nationalities
£70M+ in Research Income
Select Publications
GM-CSF drives dysregulated hematopoietic stem cell activity and pathogenic extramedullary myelopoiesis in experimental spondyloarthritis.
Regan-Komito D. et al, (2020), Nat Commun, 11
Angiocrine signals regulate quiescence and therapy resistance in bone metastasis
Singh A. et al, (2019), JCI Insight, 4
Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology.
Nayar S. et al, (2019), Proc Natl Acad Sci U S A, 116, 13490 - 13497
Distinct fibroblast subsets drive inflammation and damage in arthritis.
Croft AP. et al, (2019), Nature, 570, 246 - 251
Latest news
New therapeutic target identified in spondyloarthritis
20 January 2020
NDORMS team awarded the International Dupuytren Award
12 November 2019